key: cord-0268485-l2irhsom
authors: Schneider, K. A.; Tsoungui Obama, H. C. J.; Adil Mahmoud Yousif, N.; Ngougoue Ngougoue, P. M.
title: Predicting the impact of COVID-19 vaccination campaigns - a flexible age-dependent, spatially-stratified predictive model, accounting for multiple viral variants and vaccines
date: 2022-01-01
journal: nan
DOI: 10.1101/2021.12.29.21268526
sha: 2205c6283606cddde5366e553c5ac5c10572036c
doc_id: 268485
cord_uid: l2irhsom

Background: After COVID-19 vaccines received approval, vaccination campaigns were launched worldwide. Initially, these were characterized by a shortage of vaccine supply, and specific risk groups were prioritized. Once supply was guaranteed and vaccination coverage saturated, the focus shifted from risk groups to anti-vaxxers, the underaged population, and regions of low coverage. At the same time, hopes to reach herd immunity by vaccination campaigns were put into perspective by the emergence and spread of more contagious and aggressive viral variants. Particularly, concerns were raised that not all vaccines protect against the new-emerging variants. Methods and findings: A model designed to predict the effect of vaccination campaigns on the spread of viral variants is introduced. The model is a comprehensive extension of the model underlying the pandemic preparedness tool CovidSim 2.0 (http://covidsim.eu/). The model is age and spatially stratified, incorporates a finite (but arbitrary) number of different viral variants, and incorporates different vaccine products. The vaccines are allowed to differ in their vaccination schedule, vaccination rates, the onset of vaccination campaigns, and their effectiveness. These factors are also age and/or location dependent. Moreover, the effectiveness and the immunizing effect of vaccines are assumed to depend on the interaction of a given vaccine and viral variant. Importantly, vaccines are not assumed to immunize perfectly. Individuals can be immunized completely, only partially, or fail to be immunized against one or many viral variants. Not all individuals in the population are vaccinable. The model is formulated as a high-dimensional system of differential equations, which is implemented efficiently in the programming language Julia. As an example, the model was parameterized to reflect the epidemic situation in Germany until November 2021 and predicted the future dynamics of the epidemic under different interventions. In particular, without tightening contact reductions, a strong epidemic wave is predicted. At the current state, mandatory vaccination would be too late to have a strong effect on reducing the number of infections. However, it would reduce mortality. An emergency brake, i.e., an incidence-based stepwise lockdown would be efficient to reduce the number of infections and mortality. Furthermore, to specifically account for mobility between regions, the model was applied to two German provinces of particular interest: Saxony, which currently has the lowest vaccine rollout in Germany and high incidence, and Schleswig-Holstein, which has high vaccine rollout and low incidence. Conclusions: A highly sophisticated and flexible but easy-to-parameterize model for the ongoing COVID-19 pandemic is introduced. The model is capable of providing useful predictions for the COVID-19 pandemic, and hence provides a relevant tool for epidemic decision-making. The model can be adjusted to any country, to derive the demand for hospital and ICU capacities as well as economic collateral damages.

To bring a quick end to the ongoing COVID-19 pandemic, vaccines were developed at 2 record speed around the globe. With BNT162b2 and mRNA-1273, two mRNA-based 3 vaccines received approval for emergency or full use and were widely deployed [1, 2] . 4 Within less than two years 23 vaccines against COVID-19 received emergency-use 5 approval [3] and several vaccines successfully sought approval for teenagers and 6 children [4, 5] . Initial hopes were that herd immunity could be reached by 7 mass-vaccination [6, 7] . According to classical SIR-type models, 1 minus 1 by the basic 8 reproduction number (1-1/R 0 ) of the population needs to be immunized to reach herd 9 immunity [8, 9] . However, it is unclear to which extent the various vaccines protect from 10 infection and transmission. Empirical evidence suggests that vaccinated individuals are 11 less likely to be infected, and less likely to transmit the virus [10, 11] . Moreover, it is to the vaccine and could quickly immunize the population to end contact-reducing 29 measures [21, 22] , while Australia advocated a zero-COVID-19 strategy by maintaining 30 strict contact reductions and started vaccination campaigns late [23, 24] . However, these 31 were successful to rapidly immunize a large proportion of the population [23] . Moreover, 32 many low-income countries often neither have good access to vaccines nor the medical 33 infrastructure for deployment [25] . However, in these countries, the risk group of elderly 34 citizens is typically small [26] . Also the propensity to get vaccinated substantially varies 35 across countries depending on the level of education, trust in the available vaccine, size 36 of the risk groups, etc. For instance, Denmark pursued a strategy of not deploying the 37 AZD1222, when the occurrence of venous thromboembolism (VTE) after vaccination 38 was reported, thereby increasing confidence in the safety of the recommended 39 vaccines [27, 28] . Within countries, vaccination rates differ between age groups and 40 regions, with the younger population, which is at lower risk of severe COVID-19 41 infections, being more hesitant [29, 30] . Due to human contact behavior, age-and 42 location-dependent vaccination coverage is important to contain the spread of the virus, 43 as contact behavior is age and location dependent. 44 Despite different approaches, countries across the world keep experiencing epidemic 45 waves that ultimately need to be managed by contact-reducing interventions, such as 46 mandatory use of facial masks, frequent testing for SARS-CoV-2, cancellation of mass 47 events, curfews, and lockdowns. In addition, the effect of the spread of new viral 48 variants and the effectiveness of vaccine products against these variants are sources of 49 concern [13] . For instance, South Africa returned millions of doses of the AZD1222 50 vaccine after the vaccine's effectiveness against the Beta variant was questioned [31] . 51 Predictive models can facilitate the exploration of the effect of different vaccination 52 strategies. Here, a complex and flexible predictive model that accounts for age-and 53 location-dependent contact behavior is introduced to study the impact of different 54 epidemic management strategies. The underlying extended SEIR-type model modifies 55 and extends those of the pandemic preparedness tool CovidSim 2.0 [32] , as well as the 56 vaccination model of [33] . The model accounts for different viral variants and vaccines 57 introduced at different time points. Viral variants are characterized by different 58 contagiousness and aggressiveness. The propensity to get vaccinated, the onset of 59 vaccine deployment, the vaccination rates, the effectiveness of the vaccine products 60 against the viral variants are age, location, and time dependent. Importantly, 61 vaccinated individuals might fail to immunize, immunize only partially or completely 62 against (at least) one viral variant. Location-dependent contact-reducing interventions 63 and case isolation measures are included in the model. Contact reductions can follow an 64 incidence-based automatism. We exemplify the model by parameterizing it heuristically 65 to reflect the situation in the Federal Republic of Germany from the onset of the the text serves as a guidance on how to parameterize the model. Only a verbal 73 description of the model is presented in the main text. A concise mathematical 74 description is presented in S1 Mathematical Appendix.

The spread of different COVID-19 variants is modeled in an age-structured population 77 by an extended SEIR model, based on the pandemic preparedness tool CovidSim 78 (cf. [32] ). The model is designed to yield realistic disease dynamics and considers several 79 control interventions, such as general contact reductions, case-isolation, immunization 80 by different vaccines etc. A concise mathematical description is presented in S1 81 Mathematical Appendix, in addition to the verbal description provided here.

Age and spatial structure 83 The total population of size N is subdivided into a number of r locations. These can be 84 interpreted as metropolitan and rural areas between which migration is limited, or as 85 different countries. Furthermore, the population is age-structured, i.e., it is sub-divided 86 into s age cohorts in each location. The course of an infection is qualitatively identical for each age group, location, and 94 viral variant. An infected individual progresses through the (i) latent (not yet infectious, 95 no symptoms), (ii) prodromal (not yet infectious to the fullest extent, no symptoms), 96 (iii) fully-infectious (infectious to the fullest extent, symptoms might start), and (iv) 97 late-infectious (infectiousness is reduced) phases (Fig 1) .

In the fully-and late-infectious phases individuals can either be asymptomatic or 99 symptomatic. A fraction of infected individuals becomes symptomatic (mild or severe 100 symptoms) at the beginning of the fully-infectious phase, whereas the remaining 101 fraction remains asymptomatic. This fraction is dependent on age and the infecting 102 variant. A fraction of symptomatic individuals dies after the end of the late-infectious 103 phase (this fraction again depends on age and variant), while all others (symptomatic or 104 asymptomatic) recover and remain permanently immune against all COVID-19 variants. 105 The average duration of the various phases of the infection are dependent on age and 106 the infecting viral variant.

Implicitly, SEIR models assume exponential-distributed waiting times to progress 108 through the infectious phases. This yields unrealistic epidemic dynamics [33] . To avoid 109 this behavior, each phase of the infection is modeled by a number of equivalent All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. sub-stages through which individuals progress successively. As a consequence the 111 waiting times to progress between compartments are Erlang-distributed (cf. [32] [33] [34] [35] ).

The number of these sub-stages depends on the phase of the infection, the age group of 113 the infected individuals, and the infecting viral variant. effectiveness between the alternative vaccines and among age groups. Susceptibility to 133 the virus is reduced for partially-immune individuals (depending on age group, variant, 134 and vaccine product). Importantly, the effect of immunization against viral variants is 135 vaccine dependent. In particular, individuals can be completely immunized by a vaccine 136 against a specific viral variant, but fail to be immunized completely against some other 137 variants -however, they will also have reduced susceptibility against these variants. Individuals waiting to get vaccinated can also be vaccinated when already infected. 152 The model assumes the vaccine has no impact on infected individuals in the fully-and 153 late-infectious phases. Hence it is ignored that these individuals get vaccinated.

However, infected individuals can get vaccinated during the latent and prodromal 155 phases. In these cases they are treated like vaccinated infected individuals for whom the 156 outcome of the vaccine is still pending. Contacts between individuals is assumed to be age-and location-dependent. In 167 particular, a symmetric matrix between age strata and locations describing the contact 168 behavior has to be specified. The contact matrix changes due to general contact 169 reductions and case isolation. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 1, 2022. Model implementation 187

The model as described in detail in S1 Mathematical Appendix and was implemented in 188 Julia 1.6.3. We used the function solve using an adaptive-order adaptive-time Adams

Moulton method (VCABM ) available in the package DifferentialEquations [36] . The population of N = 83 787 388 was subdivided into four age strata (see S1 Table) 203 based on census data [38] . Regarding the contact behavior, the estimates from [39] were 204 used. (The estimated contact matrices were symmetrized and aggregated to match the 205 age strata used here -exact values are available in the Julia code.) These estimates 206 divided the contact behavior into six categories: (i) contacts at home excluding the 207 oldest age stratum, (ii) contacts at home with the oldest age stratum, (iii) contacts at 208 work, (iv) contacts in school, (v) other contacts excluding the oldest age stratum, (vi) 209 other contacts of the oldest age group. The reason to single out the oldest age group is 210

that contact restrictions can affect them differently, e.g. if elderly citizens depend on 211 nursing or live in closed facilities. Since the estimates for contact behavior are available 212 only for the whole country and estimates for mobility were unavailable to us, the model 213 was not stratified by different locations, i.e., r = 1. (In S1 Simulation results for Saxony 214 and Schleswig-Holstein the effect of more than one location is illustrated by considering 215 only two provinces of Germany, Saxony and Schleswig-Holstein, assuming hypothetical 216 contacts between locations.) Contact reductions were modeled by reducing the contacts 217 at home, work, school, and other contacts during specific time intervals by percentages 218 that roughly reflect the contact reductions imposed in Germany (see S2 Table, S3 219 Table) . From April 25, 2021 (t = 425) to July 4, 2021 (t = 495) contact reductions were 220 incidence-based, reflecting the COVID-19 emergency brake in Germany [40] (see S4 221 Table) . 44] . Also 235 August 2021 was unusually cold with 30% more rainfalls and 30% less sunshine [45] . In 236 the simulations, we adjusted for the unusually cold March/April and August 2021 (see 237 Weather adjustment in S1 Mathematical Appendix). Table) . 245 Course of infection 246 The average durations for the latent, prodromal, fully-infectious and late-infectious 247 phases were equal for all age groups and variants. They were set to D E = 3.5, D P = 1, 248 November 29, 2021 9/24

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 1, 2022. ; D I = 5, D L = 5 days, respectively. During the prodromal and late-infectious phases all 249 viral variants were assumed to be transmitted half as efficiently as in the fully-infectious 250 phase (c P = c L = 0.5, c I = 1; cf. S6 Table) . Reported quantities 261 We report disease incidence and prevalence. Disease prevalence is defined as the sum of 262 all infected individuals (in the latent, prodromal, fully-infectious, and late-infectious 263 phases). By incidence we refer to 7-day incidence, which is the number of new cases stratified by age and viral variants, respectively), as well as mortality (Fig 3C) and the 271 vaccination progress (Fig 3D) . Incidence in the model outcome subsumes unreported 272 cases. Therefore, it exceeds the the empirically observed incidence. The fraction of 273 unreported cases depends on testing capacities, the propensity to get tested, and testing 274 policies, which change over time.

The 'first wave' in Germany lasted from mid-March 2020 to mid-May 2020, had a 276 peak of approximately 100 000 active infections and was controlled by a hard lockdown. 277 The 'second wave' started in September 2020 when the basic reproduction number 278 increased due to seasonal fluctuations. The increase in incidence was reduced as stricter 279 contact-reducing measures were introduced in early November 2020 (t = 250). The 280 second wave peaked around Christmas 2020 (t = 303), followed by a decline because of 281 strict contact reductions. However, in early March 2021 (t = 370) incidence increased 282 again as the Alpha-variant became predominant (Fig 3B) , launching the 'third wave', 283 which started to decline in late April 2021 (t = 425), when an incidence-based federal 284 emergency brake was introduced. In June 2021 the Delta-variant became predominant 285 ( Fig 3B) and a fourth COVID-wave started in late August, which was unusually cold 286 (see above). A slight decline in incidence followed after weather normalized and contact 287 reductions were implemented. Finally, incidence increases again since mid-October 2021 288 (t = 597) due to seasonality in transmission.

November 29, 2021 10/24

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 1, 2022. Table to S11 Table. Simulation time is from t = 0 to t = 636. Importantly, the fraction of infections attributed to children and teenagers is higher 290 in the third and fourth wave than in the first and second wave. In the fourth wave the 291 number of infections among young children (<5 years) is higher than that among elderly 292 (Fig 3A) . This trend can reverse, depending on the epidemic management strategy (see 293 below). Note that in practice the number of unreported cases will be higher in young 294 children than adults. Over the summer 2021 the speed of vaccination campaigns started to stagnate, and 301 reached a level of approximately 66% of the population being fully vaccinated (Fig 3D) . 302 November 29, 2021 11/24

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 1, 2022. Table to S11 Table. Predictions for the flu season 2021 and epidemic management contact-reducing measures are implemented in fall/winter 2021. Incidence is predicted 312 to be almost seven times higher than in the second wave, with an epidemic peak around 313 early January 2022 (Figs 4A,C, 5A) . All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 1, 2022. Table to S11 Table. November 29, 2021 13/24

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 1, 2022. The parameters used for the simulations are listed in S1 Table to S11 Table. that of the second wave. Numbers would steadily decrease until summer 2022 (Figs 4A, 317 5B). This yields a significant reduction in mortality (Fig 4B) . The strongest effect 318 would have occurred if the emergency brake from April 2021 would have never been 319 exempt (Figs 4A,B, 5B) . A fourth wave would also have been unavoidable under this 320 scenario. This is due to seasonal fluctuations in transmissibility and the incidence-based 321 contact reductions. Importantly, the mortality would stagnate at a level, that was 322 already reached in fall 2021 (Fig 4B) .

Home schooling, i.e., closing schools, would also have an immediate effect, which 324 however is less effective than the emergency brake. It mainly slows down the increase in 325 incidence, which leads to a reduction of the epidemic peak of approximately 50% (Figs 326 4C, 5C). However, mortality is not efficiently reduced, leading to a doubling of the 327 current level (Fig 4D) .

Effect of the mutants 329 During initial vaccine development and phase III clinical studies in 2020, the wildtype 330 was still the dominating viral variant. The epidemiological strategy was to reach herd 331 immunity by large-scale vaccination campaigns to end the epidemic. However, when the 332 first vaccines were approved more aggressive viral variants started to spread. Fig 6   333 shows the course of the epidemic if the mutations would not have occurred assuming a 334 continuation of interventions from early November 2021 (scenario i). If none of the 335 mutations would have appeared, the third wave would have been milder and the fourth 336 wave would not have occurred. More precisely, the strict contact reductions after the 337 holiday season 2020 would have been sufficient. Furthermore, the vaccination campaigns 338 (Fig 6A) would have been sufficient to avoid a fourth wave and mortality would have 339 stayed below 100 000 (Fig 6B) under the current contact reductions, if the Delta variant 340 would not have occurred. Shown are the 7-day average incidence (A) and total numbers of infected individuals (B) with and without mandatory vaccination of individuals older than 12 years of age after November 22, 2021, assuming a continuation of the interventions of November 2021. Further shown are the corresponding numbers of deaths (C) and vaccinated individuals (D). The parameters used for the simulations are listed in S1 Table to S11 Table. Table to S11 Table. have emerged (Fig 6A) , and mortality would have stagnated at the level after the third 343 wave at below 100 000 (Fig 6B) .

Mandatory vaccine 345 We quantified the effect of mandatory vaccination of individuals older than 12 years of 346 age starting from November 22, 2021 (t = 636). This scenario assumes that the 347 vaccination rates are increased substantially after t = 636 to reach 95% of the population 348 older than 12 years within a relative short time period. Mandatory vaccination leads to 349 a noticeable reduction in the number of infections (Fig 7A) , however this intervention is 350 much less effective as school closures or an emergency brake. The reason is that 351 immunization is not immediate and thus not very effective during an ongoing epidemic 352 wave. However, it leads to a noticeable reduction in mortality (Fig 7B) . would have been substantially less pronounced (Fig 8A) . The occurrence of the third 358 wave due to the spread of the Alpha mutation would not have been avoided. However, 359 mortality would have been lower (Fig 8B) . If August 2021 would not have been as cold 360 (no weather adjustment) the onset of the fourth wave would have been slightly reduced 361 and delayed. The scenario simulated initially yields a slower increase in incidence, 362 followed by a slightly higher and later epidemic peak (due to the seasonal increase in 363 the basic reproduction number). However, mortality would have stayed lower (Fig 8B) . [46, 47] . However, the Danish government had to reinstate restrictions as 370 COVID-19-related hospitalizations started to rise again [48] . Similarly, after Israel 371 're-opened the country' in summer 2021, it experienced a strong fourth COVID-19 wave, 372 although a large part of the population was already vaccinated [49] [50] [51] . Globally 373 vaccination campaigns do not everywhere progress as fast as in Israel or Denmark, e.g., 374 in many countries in sub-Saharan Africa, relatively few people are vaccinated [52] . This 375 is partly due to the demography with 50% of the population being under-aged and less 376 than 2% of the population being older than 70 years of age [53] . Hence, the COVID-19 377 risk group is small, while vaccines are not even approved for the majority of the 378 population. This leads to a different assessment of the benefits of vaccines. In any case, 379 the effects of vaccination campaigns in different countries across the globe are uncertain 380 and predictive models are an important tool to assist epidemic decision making. mentioned. New mutants enter the model by an external force of infection, i.e., infective 392 contacts with individuals from outside the considered population. Importantly, the 393 model is age-stratified, to account appropriately for the age-dependent contact behavior, 394 which substantially influences the dynamics of the epidemic [54]. The age structure of 395 the population also needs to be addressed to adequately model vaccination campaigns. 396 In fact, many countries prioritize certain age groups in dispersing the vaccine, and most 397 of the vaccines are not approved or recommended for all age groups (cf. [13] [14] [15] ). The 398 model further accounts for time-dependent vaccine supply. Moreover, the model 399 captures that vaccine products differ in their effectiveness, the vaccination schedule, and 400 the protectiveness from infection and transmission. Namely, it is empirically proven that 401 not all vaccine is equally effective against each viral variant (cf. [13] , and COVID-19 402 vaccines do not protect from infection and transmission [55] . A reason could be that 403 vaccines trigger the production of immunoglobulin G, while immunoglobulin A is the 404 antibody class being prevalent in the mucous membrane, through which the virus enters 405 the human body [56, 57] . The model allows specifying how much each vaccine protects 406 against the various viral variants regarding infectiveness, transmissibility, occurrence of 407 symptoms, and mortality. The model is also spatially stratified. Hence, it can be used 408 as a pandemic model subsuming several countries. Notably, the spatial stratification can 409 also be important when the model is applied to a single country. For instance, many 410 countries in sub-Saharan Africa are large by area, but the inhabited parts are often 411 concentrated on a handful of metropolitan areas. In such countries the contact behavior 412 is not random, neither between age groups nor between locations (metropolitan areas). 413 Even in countries, in which the population distributes evenly across the area, contacts 414 between individuals might depend sensitively on mobility. Such a spatial structure can 415 often be modeled on a continuous scale (mathematically in terms of partial differential 416 equations -PDE). However, the situation is also captured by the model introduced here, 417 because it can be interpreted as a discretization of a PDE model.

A model as flexible as the one presented here involves numerous parameters. 419 However, the proposed model is still easy to parameterize as demonstrated by the campaigns or the vaccination rates per age group and location can be easily estimated 431 from official data.

The most difficult parameters involved are those defining the age-and 433 location-dependent contact behavior. For the age-dependent contact behavior, estimates 434 for 152 countries are given in [39] . The contacts are subdivided into interactions 435 happening at home, at work, in school, and at other places. These estimates can be 436 further aggregated or disaggregated as needed. However, spatial contact behavior is 437 more difficult. In general, mobility can be estimated from cell-phone data or air-traffic 438 data [58, 59] . While this might be simple for countries in which the population is 439 concentrated in a few metropolitan areas, in more evenly distributed populations it will 440 be much more difficult to estimate contacts at a fine-grained level.

As an example for the model's applicability, we parameterized the model to reflect 442 the situation in Germany. Because adequately estimating mobility data would have 443 exceeded the scope of this article, we modeled Germany as a single location. The contact 444 behavior was estimated from the contact matrices in [39] , which allowed us to model the 445 effects of specific contact reductions such as school closures, working from home, etc.

The numerical results for Germany accurately reflect the past dynamics of the 447 epidemic and a severe 'fourth wave' is predicted. According to the model, the 448 introduction of mandatory vaccines for individuals older than 12 years of age at the 449 current state of the epidemic in Germany would not have a substantial effect on the 450 number of infections. However, it has a substantial effect on reducing mortality. Closing 451 schools would lead to a stronger reduction in the number of infections, but does not lead 452 to an equally strong reduction in mortality. Not surprisingly, an incidence-based 453 emergency brake, i.e., a stepwise lockdown based on incidence thresholds would be the 454 most efficient measure to reduce incidence and mortality. The epidemic waves in adjustments'.

To demonstrate the applicability of the model to multiple locations, in S1 Simulation 461 results for Saxony and Schleswig-Holstein we presented predictions for two spatially 462 separate German provinces, i.e., Saxony and Schleswig-Holstein, assuming hypothetical 463 mobility between these two locations. The two provinces were selected, because (i) they 464 are distant and mobility exchange is sufficiently low to heuristically define the contact 465 behavior between locations, rather than relying on accurate mobility data; and (ii) these 466 provinces differ in a number of important characteristics. Saxony has currently the 467 lowest vaccination rollout among all German provinces, while Schleswig-Holstein has 468 one of the highest. Moreover, Saxony has currently the highest COVID-19 incidence in 469 Germany although the fourth epidemic wave started there later than in other provinces. 470 In Schleswig-Holstein the fourth wave started relatively early, but incidence is currently 471 lower than in most other provinces. Infective contacts with other provinces and All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted January 1, 2022. ; https://doi.org/10.1101/2021.12.29.21268526 doi: medRxiv preprint S5 

BNT162b2 mRNA COVID-19 vaccine: First approval

American 522 journal of obstetrics & gynecology MFM

COVID-19 vaccines for children younger than 12 years: are we 527 ready? The Lancet Infectious Diseases

Vaccines for 529 COVID-19: where do we stand in 2021?

Five reasons why COVID herd immunity is probably impossible. 531 Nature

Core Concept: Herd immunity is an important-and often 533

Herd immunity": a rough guide

The disease-induced herd immunity level for 538

Covid-19 is substantially lower than the classical herd immunity level

Understanding COVID-19 vaccine efficacy

Effect of 543 vaccination on transmission of COVID-19: an observational study in healthcare 544 workers and their households

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy

Switching vaccination among target groups to 553 achieve improved long-lasting benefits

A 556 global database of COVID-19 vaccinations

Vaccine hesitancy in the COVID-19 era

COVID-19 vaccines: addressing 561 hesitancy in young people with allergies. The Lancet Respiratory Medicine

COVID-19 vaccination uptake

COVID-19 vaccination hesitancy and challenges to mass vaccination

Covid-19 vaccination should be mandatory for healthcare workers

Why Does Israel Lead the World in COVID

Vaccinations? Applying Mass Casualty Event Principles to COVID-19

Vaccination Programs

Signals of hope: gauging the impact of a rapid 575 national vaccination campaign

Navigating 577 from SARS-CoV-2 elimination to endemicity in Australia

The Australian response to the COVID-19 581 pandemic: A co-ordinated and effective strategy. Anaesthesia, critical care & 582 pain medicine

COVID-19 vaccine access in Africa

Global distribution, vaccine platforms, and challenges ahead

Who should be prioritised for COVID-19 vaccination? 587 Human Vaccines & Immunotherapeutics

COVID-19: Vaccines to prevent SARS-CoV-2 infection

covid-19-vaccines-to-prevent-sas-cov-2-infection

Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after 593 vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark

The Association Between Risk Perception and COVID-19 596

Vaccine Hesitancy for Children Among Reproductive Women in China: An 597

Online Survey. Frontiers in medicine

Trajectory of COVID-19 Vaccine Hesitancy Over Time and Association of Initial 600

Vaccine Hesitancy With Subsequent Vaccination

Africa wants to return 1 million AstraZeneca vaccine doses to 603 Serum Institute: report; 2021

The COVID-19 Pandemic Preparedness Simulation Tool

The impact of COVID-19

COVID-19 spread in closed facilities by regular testing of employees-An efficient 615 intervention in long-term care facilities and prisons? PLOS ONE

Is increased mortality by multiple exposures to COVID-19 an overseen 619 factor when aiming for herd immunity? PloS one

ecosystem for solving differential equations in julia

R: A language and environment for statistical computing. 625 Accessed 1st

Federal Statistical Office Germany: Statistics: 12411

Projecting social contact matrices in 152 countries 630 using contact surveys and demographic data

Attitudes towards the 633 economic costs associated with measures against the spread of COVID

Population perceptions from repeated cross-sectional data of the nationally 635

COVID-19 Snapshot Monitoring in Germany (COSMO)

Covid-19: How many variants are there, and what do we know about 638 them?

Covid-19 Delta variant

Frosty April: The Easter month was the coldest in 40 years in 643

The vegetation suffered particularly from the many days of frost

August was 30 percent too 650 wet and the sun shone 30 percent too little

The effect of non-pharmaceutical interventions on the 654 demand for health care and on mortality: evidence from COVID-19 in 655

Denmark's high vaccination rate sees COVID pass ended for 657 restaurants

denmark-s-high-vaccination-rate-sees-covid-pass-ended-for-restaurants

Denmark Will Bring Back Some Restrictions as Covid-19 Cases Soar

COVID: Why are infections rising in Israel?

Israel to readmit COVID-vaccinated foreign tourists next month

Health Ministry chief: Israel's 4th COVID wave appears 670

Covid-19 vaccinations: More than 50 nations have missed a target set 673 by the WHO

Socio-demographic and epidemiological consideration of Africa's COVID-19 676 response: what is the possible pandemic course?

Mathematical Modelling of Infectious Diseases COVID-19 Working Group, et al. 680 Projecting contact matrices in 177 geographical regions: An update and 681 comparison with empirical data for the COVID-19 era

Limited protection against SARS-CoV-2 infection and virus transmission after 685 mRNA vaccination

Prediction and mitigation of mutation 688 threats to COVID-19 vaccines and antibody therapies. Chemical science

COVID-19: a neglected but critical aspect of SARS-CoV-2 infection

Dissecting global air 694 traffic data to discern different types and trends of transnational human mobility

Understanding human mobility 697 flows from aggregated mobile phone data. IFAC-PapersOnLine